Literature DB >> 15080557

Modulation of plasma fibrinogen levels in acute-phase response after hepatectomy.

Ivo Giovannini1, Carlo Chiarla, Felice Giuliante, Maria Vellone, Gennaro Nuzzo.   

Abstract

In acute-phase response, the use of amino acids is redirected to supporting the synthesis of proteins for host defence and tissue repair. Fibrinogen is one of these proteins, and its plasma levels commonly increase in acute-phase conditions. After hepatectomy, this pattern may be modified by the variable impact of postoperative liver dysfunction. Our study was performed to specifically assess and quantify this aspect. Data were collected prospectively on 82 hepatectomized patients; 62 recovered normally, 20 had major complications (most commonly sepsis). Plasma fibrinogen and a large series of complementary variables were determined preoperatively and at postoperative days 1, 3 and 7 in all patients and until recovery, or death in those with complications. Multiple regression analysis showed that postoperative changes in fibrinogen (deltaFIB, micromol/l) were simultaneously related to the number of resected liver segments (NSEG), total bilirubin (BIL, micromol/l), aspartate aminotransferase (AST, U/l, n.v. 5-45), albumin (ALB, g/l), prothrombin activity (PA, % of standard reference), age (AGE, years) and basal preoperative fibrinogen (PFIB, micromol/l): deltaFIB = -0.51(NSEG) - 0.71(Log(n)BIL) - 0.74(Log(n)AST) + 0.11(ALB) + 0.09(PA) - 0.06(AGE) - 0.55(PFIB) + 7.74 (n=362, r2=0.68, p<0.001). In addition, an early postoperative tendency for low fibrinogen was associated with the subsequent development of complications or death. Our study quantifies the impact of size of hepatectomy and dysfunction of residual liver in modulating postoperative fibrinogen level and suggests that failure of fibrinogen to increase may signal an unfavorable condition limiting up-regulation of acute-phase response and increasing liability to complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15080557     DOI: 10.1515/CCLM.2004.048

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

Review 1.  Systematic review of pathophysiological changes following hepatic resection.

Authors:  Joey Siu; John McCall; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

Review 2.  [Coagulation management in patients with liver disease].

Authors:  A Bienholz; A Canbay; F H Saner
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-05-05       Impact factor: 0.840

Review 3.  Hemostasis and Liver Regeneration.

Authors:  Patrick Starlinger; James P Luyendyk; Dafna J Groeneveld
Journal:  Semin Thromb Hemost       Date:  2020-09-09       Impact factor: 4.180

4.  Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time.

Authors:  Myung S Park; Wenjun Z Martini; Michael A Dubick; Jose Salinas; Saulius Butenas; Bijan S Kheirabadi; Anthony E Pusateri; Jeffrey A Vos; Charles H Guymon; Steven E Wolf; Kenneth G Mann; John B Holcomb
Journal:  J Trauma       Date:  2009-08

5.  Early Morbidity and Mortality after Minimally Invasive Liver Resection for Hepatocellular Carcinoma: a Propensity-Score Matched Comparison with Open Resection.

Authors:  Dimitrios Xourafas; Timothy M Pawlik; Jordan M Cloyd
Journal:  J Gastrointest Surg       Date:  2018-10-30       Impact factor: 3.452

6.  Parenteral nutrition in liver resection.

Authors:  Carlo Chiarla; Ivo Giovannini; Felice Giuliante; Francesco Ardito; Maria Vellone; Agostino Maria De Rose; Gennaro Nuzzo
Journal:  J Nutr Metab       Date:  2012-03-29

7.  Proof-of-concept Studies for siRNA-mediated Gene Silencing for Coagulation Factors in Rat and Rabbit.

Authors:  Zhu Chen; Bin Luo; Tian-Quan Cai; Anil Thankappan; Yiming Xu; Weizhen Wu; Jillian DiMuzio; Traci Lifsted; Marty DiPietro; Jyoti Disa; Bruce Ng; Karen Leander; Seth Clark; Lizbeth Hoos; Yuchen Zhou; Nina Jochnowitz; Christine Jachec; Peter Szczerba; Marian E Gindy; Walter Strapps; Laura Sepp-Lorenzino; Dietmar A Seiffert; Laura Lubbers; Marija Tadin-Strapps
Journal:  Mol Ther Nucleic Acids       Date:  2015-01-27       Impact factor: 10.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.